Table 1.
Characteristics of patients
| Characteristics | CR (N = 34) |
PR (N = 29) |
PD/SD (N = 11) |
Total (N = 74) |
p Value |
|---|---|---|---|---|---|
| Gender | |||||
| Female Male |
15 (44) 19 (47.5) |
15 (44) 14 (35) |
4 (12) 7 (17.5) |
34 (46) 40 (54) |
|
| Age (years) | |||||
| <65 >65 |
13 (56) 21 (41) |
8 (35) 21 (41) |
2 (9) 9 (18) |
23 (31) 51 (69) |
|
| Disease | 0.0085 | ||||
| High grade NHL Other low grade NHL |
20 (67) 14 (32) |
6 (20) 23 (52) |
4 (13) 7 (16) |
30 (41) 44 (59) |
|
| CMV status | |||||
| Positive Negative ND |
13 (52) 13 (45) 8 (40) |
9 (36) 13 (45) 7 (35) |
3 (12) 3 (10) 5 (25) |
25 (34) 29 (39) 20 (27) |
|
| CD16 genotype | 0.4656 | ||||
| VV VF FF |
3 (37.5) 14 (41) 17 (53) |
3 (37.5) 13 (38) 13 (41) |
2 (25) 7 (21) 2 (6) |
8 (11) 34 (46) 32 (43) |
|
| HLA-C ligands | 0.569 | ||||
| C1C1 C1C2 C2C2 |
10 (39) 19 (50) 5 (50) |
11 (42) 13 (34) 5 (50) |
5 (19) 6 (16) 0 (0) |
26 (35) 38 (51) 10 (14) |
|
| HLA-A/B Bw4 ligands | 0.5216 | ||||
| Bw4+ Bw4- |
22 (43) 12 (52) |
21 (41) 8 (35) |
8 (16) 3 (13) |
51 (69) 23 (31) |
|
| HLA-A3/A11 ligands | 0.8716 | ||||
| A3/A11+ A3/A11- |
10 (42) 24 (48) |
10 (42) 19 (38) |
4 (16) 7 (14) |
24 (32) 50 (68) |
Data are presented as n (%).
Abbreviations: CR: Complete response; PR: partial response; SD: stable disease; PD: progressive disease; CMV: cytomegalovirus; HLA: Human Lymphocytic Antigen.